ORIGINAL RESEARCH
Accepted on 03 Oct 2025
Investigating subregional PD-L1 expression within primary tumor to predict clinical outcome in advanced NSCLC patients who received ICB-based therapy
doi 10.3389/fonc.2025.1497279
- 853 views
- Frontiers in Oncology
- Thoracic Oncology
- Research Topics
- Biomarker-Guided Strategies in NSCLC Immunotherapy
Biomarker-Guided Strategies in NSCLC Immunotherapy
3,851
Total downloads
16k
Total views and downloads
Articles
REVIEW
Published on 19 Dec 2024
Biomarkers for immunotherapy resistance in non-small cell lung cancer
doi 10.3389/fonc.2024.1489977
- 3,875 views
- 7 citations
ORIGINAL RESEARCH
Published on 15 Nov 2024
Advancing EGFR mutation subtypes prediction in NSCLC by combining 3D pretrained ConvNeXt, radiomics, and clinical features
doi 10.3389/fonc.2024.1464555
- 1,368 views
ORIGINAL RESEARCH
Published on 04 Nov 2024
The causal nexus between diverse smoking statuses, potential therapeutic targets, and NSCLC: insights from Mendelian randomization and mediation analysis
doi 10.3389/fonc.2024.1438851
- 1,519 views
- 2 citations
SYSTEMATIC REVIEW
Published on 11 Oct 2024
Prognostic significance of the modified Glasgow Prognostic Score in NSCLC patients undergoing immune checkpoint inhibitor therapy: a meta-analysis
doi 10.3389/fonc.2024.1449853
- 1,789 views
- 1 citation
ORIGINAL RESEARCH
Published on 26 Sep 2024
PD-1 expression in tumor infiltrating lymphocytes as a prognostic marker in early-stage non-small cell lung cancer
doi 10.3389/fonc.2024.1414900
- 1,671 views
- 2 citations
ORIGINAL RESEARCH
Published on 21 May 2024
Association of PD-L1 expression and clinical outcomes in ROS1 - rearranged advanced non-small cell lung cancer treated with crizotinib
doi 10.3389/fonc.2024.1405683
- 1,376 views
- 1 citation
